JP2023518208A5 - - Google Patents

Info

Publication number
JP2023518208A5
JP2023518208A5 JP2022555078A JP2022555078A JP2023518208A5 JP 2023518208 A5 JP2023518208 A5 JP 2023518208A5 JP 2022555078 A JP2022555078 A JP 2022555078A JP 2022555078 A JP2022555078 A JP 2022555078A JP 2023518208 A5 JP2023518208 A5 JP 2023518208A5
Authority
JP
Japan
Prior art keywords
alkyl
therapeutic agent
amino
agent according
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022555078A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023518208A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/080540 external-priority patent/WO2021180219A1/zh
Publication of JP2023518208A publication Critical patent/JP2023518208A/ja
Publication of JP2023518208A5 publication Critical patent/JP2023518208A5/ja
Pending legal-status Critical Current

Links

JP2022555078A 2020-03-13 2021-03-12 Pi4k阻害物質の抗コロナウイルス効果および応用 Pending JP2023518208A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202010177429.3 2020-03-13
CN202010177429 2020-03-13
PCT/CN2021/080540 WO2021180219A1 (zh) 2020-03-13 2021-03-12 Pi4k抑制剂的抗冠状病毒效果以及应用

Publications (2)

Publication Number Publication Date
JP2023518208A JP2023518208A (ja) 2023-04-28
JP2023518208A5 true JP2023518208A5 (cg-RX-API-DMAC10.html) 2024-03-21

Family

ID=77672132

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022555078A Pending JP2023518208A (ja) 2020-03-13 2021-03-12 Pi4k阻害物質の抗コロナウイルス効果および応用

Country Status (10)

Country Link
US (1) US20250152599A1 (cg-RX-API-DMAC10.html)
EP (1) EP4119164A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023518208A (cg-RX-API-DMAC10.html)
KR (1) KR20230022150A (cg-RX-API-DMAC10.html)
CN (1) CN115884789B (cg-RX-API-DMAC10.html)
AU (1) AU2021236089B2 (cg-RX-API-DMAC10.html)
CA (1) CA3170611A1 (cg-RX-API-DMAC10.html)
MX (1) MX2022011138A (cg-RX-API-DMAC10.html)
WO (1) WO2021180219A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202210111B (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2024004055A (es) * 2021-09-30 2024-06-19 Nuo Beta Pharmaceutical Tech Shanghai Co Ltd Compuesto de oxido de fenilarsina halogenado y aplicacion del mismo.
CN117695281B (zh) * 2023-12-26 2024-06-21 广州医科大学 四氢喹啉酮-酰胺-噻唑类化合物的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923895A (en) * 1988-10-24 1990-05-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of treatment of human immunodeficiency virus
US5532154A (en) * 1994-03-21 1996-07-02 Research Development Foundation Mutated alpha virus
EP0981344A1 (en) * 1997-05-14 2000-03-01 The University of New Mexico Inhibition of cell surface protein disulfide isomerase
AU2149600A (en) * 1998-11-12 2000-05-29 Musc Foundation For Research Development Methods and compositions for treating common cold symptoms
CN1914226B (zh) * 2003-11-25 2012-02-01 达纳-法伯癌症研究院有限公司 SARS-CoV抗体及其使用方法
US7592322B2 (en) * 2004-10-22 2009-09-22 Alnylam Pharmaceuticals, Inc. RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof
WO2009121219A1 (zh) * 2008-04-02 2009-10-08 Ding Xinkan 砷化物在制备抗病毒药物中的应用
WO2012174312A2 (en) * 2011-06-15 2012-12-20 Glaxosmithkline Llc Benzimidazole derivatives as antiviral agents
WO2015135652A1 (en) * 2014-03-12 2015-09-17 Technische Universität München Antagonists of acid lipase for preventing virus infection
WO2016172952A1 (zh) * 2015-04-30 2016-11-03 江苏挪贝肽医药科技有限公司 PI4KIIIα蛋白及相关的膜蛋白复合体在治疗阿尔茨海默病中的应用
ES3010661T3 (en) * 2016-02-26 2025-04-04 Univ Leland Stanford Junior Pi-kinase inhibitors with anti-infective activity
CN108721622B (zh) * 2017-04-14 2022-10-25 中国科学院上海高等研究院 抑制肝纤维化的试剂及应用
EP4130014A4 (en) * 2020-03-31 2024-05-15 Nuo-Beta Pharmaceutical Technology (Shanghai) Co., Ltd. Deuterated oxophenylarsine compound and use thereof

Similar Documents

Publication Publication Date Title
CN107693797B (zh) 肽寡核苷酸缀合物
JP6294889B2 (ja) ウイルス疾患の処置におけるmek阻害物質
TW201623265A (zh) 抗病毒化合物、醫藥組合物及其使用方法
TW201542538A (zh) 抗病毒化合物、醫藥組合物及其使用方法
JP2010501584A5 (cg-RX-API-DMAC10.html)
JP2014526456A (ja) 過剰増殖性疾患、好ましくはp53機能欠損の治療に用いるためのCIP2Aサイレンシング剤を含む併用薬剤
JP2014505107A5 (cg-RX-API-DMAC10.html)
TW201907009A (zh) 用於治療b型肝炎之治療組成物及方法
JP2024530956A5 (cg-RX-API-DMAC10.html)
TW201625573A (zh) 色烯酮(chromenone)抗病毒化合物、醫藥組合物及其使用方法
BR112020018601A2 (pt) Regime de dosagem de modulador de montagem de capsídeo
WO2019046287A1 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEPATITIS B
CN115884789A (zh) Pi4k抑制剂的抗冠状病毒效果以及应用
JP2022529061A5 (cg-RX-API-DMAC10.html)
CA2738070C (en) Novel compounds for the treatment or alleviation of edema, and methods for their use
CN118401665A (zh) 具有高稳定性和基因沉默活性的小干扰rna分子的修饰模式
CN114729360A (zh) 降低病毒分子水平的方法
US10358447B2 (en) Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same
US20240216365A1 (en) Methods and uses of protein disulfide isomerase inhibitory compounds
JP7590351B2 (ja) Prmt5阻害剤を使用した癌の治療法
JP2022550072A5 (cg-RX-API-DMAC10.html)
CN114057816B (zh) 富含腺嘌呤硫代磷酸酯化寡核苷酸及其抗肝炎病毒的应用
JP2021529189A5 (cg-RX-API-DMAC10.html)
US20230364074A1 (en) Compounds and Compositions for Disrupting Programmed Ribosomal Frameshifting
JP2015527316A5 (cg-RX-API-DMAC10.html)